Concepedia

The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data

Wietske Kievit, Eddy Adang, Jaap Fransen, H. H. Kuper, M.A.F.J. van de Laar, Tim Jansen, C.M.A. de Gendt, D-J R A M de Rooij, H.L.M. Brus, P.C.M. van Oijen,

Annals of the Rheumatic Diseases · 2008 · 118 citations · 16 references

DOI

Concepts

References

16

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne · PubMed · 1992 · 34K citations

, , +16

The MOS 36-ltem Short-Form Health Survey (SF-36)

John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.8K citations

, , +16

EuroQol - a new facility for the measurement of health-related quality of life

Health Policy · 1990 · 15.8K citations

, , +11

Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

M.L.L. Prevoo, Martin A. van't Hof, H. H. Kuper et al. · Arthritis & Rheumatism · 1995 · 6.2K citations

, , +15

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

, , +17